Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
The Food and Drug Administration (FDA) has authorized marketing of a new diagnostic test, cobas vivoDx MRSA (Roche Molecular Systems Inc), to detect methicillin-resistant Staphylococcus aureus (MRSA) ...
The Illinois Department of Public Health announced the publication of the first infection surveillance data on Clostridium difficile and methicillin-resistant Staphylococcus aureus rates from lab ...
The CDC estimates around 5% of U.S. hospital patients carry MRSA infections on their skin or in in their nose. In many cases, these carriers will never develop harmful infections with MRSA. However, ...
Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA) "It is important that healthcare professionals have ...
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...
For the first time, Illinois hospitals have released data on the rates of Clostridium difficile and methicillin-resistant Staphylococcus aureus from lab results. This data is available on the Illinois ...
The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) ...
> Australian scientists have designed a cheap-to-manufacture stethoscope that can be attached to a smartphone, hoping to improve access to medical care in the Third World. News > Becton, Dickinson's ...
A quick MRSA superbug test developed at the Translational Genomics Research Institute and Northern Arizona University has been issued its first patent. The one-hour test can detect MRSA, a family of ...
A speedy screening method for MRSA can dramatically reduce the superbug’s spread in hospitals when coupled with the pre-emptive isolation of patients, researchers claim. The new technology, developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results